ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Comparative analysis of national regulatory frameworks for medicinal products containing controlled substances in nine selected EU Member States and the United Kingdom
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics#215684
- Data supporting 'Exploring medicines shortages within the UK community pharmacy setting'#339297
- Evolution of community pharmacy services in the European Union and beyond: a cross-country survey of 33 national pharmacy organisations.#375357
- The Geopolitics of Poison: Regulatory Asymmetries of Pesticides Between the Global South and the European Union#137314
- 21 CFR Part 1302 — Labeling and Packaging Requirements for Controlled Substances#506942
Record · ID 435549
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive